Home
http://www.virbac.fr/ http://www.boehringer-ingelheim.com/ http://www.novartis.com/ http://www.animalhealth.bayerhealthcare.com/
vetcontact
Vetrinär
Tiermedizin
  WELCOME  
vetcontact
Vetrinär
Tiermedizin
  Home  
  Login / Newsletter  
vetcontact
Vetrinär
Tiermedizin
  CONTACTS  
vetcontact
Vetrinär
Tiermedizin
  Classifieds  
  New Products  
  VetCompanies  
  VetSchools  
vetcontact
Vetrinär
Tiermedizin
  PROFESSION  
vetcontact
Vetrinär
Tiermedizin
  Edutainment  
  VetAgenda  
  Presentations  
  Posters  
  ESAVS  
  Specialisation  
vetcontact
Vetrinär
Tiermedizin
  INSIGHT  
vetcontact
Vetrinär
Tiermedizin
  Congress News  
  Picture Galleries  
vetcontact
Vetrinär
Tiermedizin
  PRODUCTS  
vetcontact
Vetrinär
Tiermedizin
  Bayer  
  Boehringer Ing.  
  Novartis  
  Virbac

 
  Simply book for less...  
    

Bovine    Equine    Small Animal Practice    Swine Practice    Articles    Vetjournal    
deutsch english español polski francais
Home / WELCOME / Archiv / Small Animal Practice /     
 
Imidacloprid/moxidectin combination against naturally acquired canine scabies
Scabies (sarcoptic mange) is a common and highly pruritic disease in dogs which often is misdiagnosed as an allergy. Some therapies are very efficious but not licensed in dogs. Is the licensed and very comfortable therapy with an imidacloprid plus moxidectin spot-on formulation both licensed and efficious?

The study was undertaken to evaluate and compare the efficacy of an imidacloprid (10% w/v) / moxidectin (2.5% w/v) combination (Advocate® Bayer HealthCare, Animal Health) with that of selamectin for the treatment of Sarcoptes scabiei on dogs.

Thirty naturally infested dogs, of which one was later withdrawn because of distemper, were allocated to two equal groups and individually housed.

The dogs in each group were treated twice, four weeks apart, with either the combination product (0.1 mL/kg body weight) or with selamectin (0.05 mL/kg body weight) administered topically. Skin scrapings were made every 14 days over a period of 50 to 64 days after the first treatment to quantify mite numbers.

Clinical signs and the extent of sarcoptic lesions were assessed on each dog when skin scrapings were made.

Efficacy was based on the presence or absence of mites, supported by clinical signs associated with canine sarcoptic mange. From Day 22 and onwards no Sarcoptes mites were found in the skin scrapings of any of the treated dogs.

Treatment with the imidacloprid/moxidectin formulation or with selamectin was highly effective against Sarcoptes scabiei and resulted in an almost complete resolution of clinical signs within 50 to 64 days after the initial treatment.


Source: LJ FOURIE, J. HEINE, IG HORAK (2006): The efficacy of an imidacloprid/moxidectin combination against naturally acquired Sarcoptes scabiei infestations on dogs. In: Australian Veterinary Journal 84 (1-2), 17–21.


Tell a friend   |   Print version   |   Send this article

SMALL ANIMAL PRACTICE

Surgical outcome of cats treated for aqueous humor misdirection syndrome
Feline aqueous humor misdirection syndrome is occasionally seen in cats and can be difficult to treat. This recently online published case series evaluates the clinical outcome of cats treated surgically for aqueous humor misdirection syndrome.

  • Treatment of limbal melanoma with surgical debulking plus diode laser
  • Novel technique to place feeding tubes in small animalsmembers
  • Epidemiology and clinical presentation of canine cataracts in France
  • Use of a Surgical Safety Checklistmembers
  • NGAL in dogs with chronic kidney diseasemembers
  • Long-term Outcome of Irish Wolfhound Dogs with different heart medicationsmembers
  • Simple technique for autotransfusion in dogsmembers
  • General anesthesia with an injectable 8% v/v sevoflurane lipid emulsion in dogsmembers
  • Carboplatin sustained-release delivery system in dogs with cancermembers
  • Wound bio-burden and prevalence of multi-drug resistant bacteria in open woundsmembers
  • Concurrent perioperative use of marbofloxacin and cimicoxib or carprofenmembers
  • Topical hyaluronic acid and the corneal wound healing members


  • [ Home ] [ About ] [ Contact / Request ][ Disclaimer ]

    Copyright © 2001-2016 VetContact GmbH
    All rights reserved